Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cripto blockade enhances embryonic stem cell transplant in Parkinson's disease model

Jan. 29, 2009

Lipoic acid slows Alzheimer's disease progression

Jan. 29, 2009

Addex announces successful completion of phase I program of ADX-48621

Jan. 28, 2009

Orexo and NovaMed sign licensing and distribution agreement for Abstral in China

Jan. 28, 2009

MHRA grants approval to Cortex to initiate study of CX-1739 in sleep apnea

Jan. 28, 2009

GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model

Jan. 28, 2009

CLK-1 inhibition may explain the effect of clioquinol in neurodegenerative diseases

Jan. 28, 2009

EpiCept reports positive results from phase IIb EpiCept trial

Jan. 28, 2009

MAP completes patient enrollment in phase III clinical trial of MAP-0004

Jan. 27, 2009

Glenmark files phase I trial application with MHPRA for GRC-15300

Jan. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.